Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha-V (αv) integrin family is a group of heterodimeric cell surface receptors that play crucial roles in cell adhesion, migration, and signaling. They are composed of an αv subunit (ITGAV gene) paired with various β subunits (β1, β3, β5, β6, and β8), forming distinct integrins such as αvβ1, αvβ3, αvβ5, αvβ6, and αvβ8. These receptors bind to extracellular matrix (ECM) proteins like vitronectin, fibronectin, fibrinogen, osteopontin, and laminins via RGD motifs. They mediate bidirectional signaling across the cell membrane, influencing cytoskeletal organization and gene expression. Certain members, like αvβ6 and αvβ8, regulate TGF-β activation. Their involvement in angiogenesis, fibrosis, and cancer progression makes them therapeutic targets.
Inhibition of integrin-ligand binding; modulation of downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-V Integrin Family (αv Integrins).